These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18018538)

  • 1. [Multidrug resistant tuberculosis: what is the risk in france?].
    Bouvet E
    Rev Prat; 2007 Sep; 57(13):1405-8. PubMed ID: 18018538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H; Schaberg T; Gillissen A
    Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
    Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
    Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of multidrug-resistant tuberculosis: Update 2007.
    Yew WW; Leung CC
    Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-resistant tuberculosis: controversies and challenges in pediatrics.
    Smith KC; Seaworth BJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):995-1010. PubMed ID: 16307511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan.
    Ano H; Matsumoto T; Suetake T; Nagai T; Tamura Y; Takamatsu I; Iwasaki T; Matsuoka H; Sasada S; Tetsumoto S; Tsuyuguchi I; Kusunoki Y; Takashima T
    Int J Tuberc Lung Dis; 2008 Nov; 12(11):1300-5. PubMed ID: 18926041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR; Shah NS; Gandhi N; Moll T; Friedland G;
    J Infect Dis; 2007 Dec; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired drug resistance pattern in tuberculosis cases at the State Tuberculosis Centre, Delhi, India.
    Hanif M; Malik S; Dhingra VK
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):74-8. PubMed ID: 19105882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistant tuberculosis.
    Singh M; Jayanthi S; Kumar L
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S41-6. PubMed ID: 11129907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuberculosis in Europe and Poland--new molecular families and new resistance patterns].
    Augustynowicz-Kopeć E; Zwolska Z
    Przegl Epidemiol; 2008; 62(1):113-21. PubMed ID: 18536233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
    Caminero JA
    Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.